Addiction

Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc

Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"…

8 months ago

Futures Recovery Healthcare Announces Collaboration with Family Recovery Collective to Expand Support for Families Impacted by Addiction and Mental Health Challenges

TEQUESTA, Fla., May 27, 2025 /PRNewswire/ -- Futures Recovery Healthcare, a leading provider of comprehensive addiction and mental health treatment,…

8 months ago

Recovery.com Expands AI Capabilities with Acquisition of RedFox AI

The acquisition reinforces Recovery.com's mission to simplify access to mental health and addiction treatment MADISON, Wis., May 21, 2025 /PRNewswire/…

9 months ago

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of…

9 months ago

Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes 

DENVER, May 19, 2025 (GLOBE NEWSWIRE) -- Porch Light Health (PLH) has partnered with CHESS Health to use its innovative,…

9 months ago

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GLEN ALLEN, Va., May 15, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage…

9 months ago

Psych Hub Honored with 2025 Health Tech World Award for Mental Health Innovation

NASHVILLE,  Tenn., May 14, 2025 /PRNewswire/ -- Psych Hub, the leading platform advancing evidence-based behavioral health education and care navigation,…

9 months ago

Massachusetts University First to Pilot NALCAM, a New Technology Advancing Naloxone Carriage and Overdose Prevention

BOSTON, May 13, 2025 /PRNewswire/ -- Q2i, a leader in digital health innovation, has launched NALCAM, a pioneering technology designed…

9 months ago

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

Milestone Achieved as Adovate Initiates First-in-Human Study for Novel Asthma Therapy Targeting Underserved, Multi-Billion Dollar MarketGlen Allen, Va., May 13,…

9 months ago

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty…

9 months ago